Back
Supernus Pharmaceuticals Stock Predictions
Better Than Oil Stocks
CLICK HERE TO FIND OUT MORE
Sell
28
SUPN
Supernus Pharmaceuticals
Last Price:
36.12
Seasonality Move:
6.46%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)Supernus Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Supernus Pharmaceuticals has on average historically risen by 20.3% based on the past 12 years of stock performance.
- Supernus Pharmaceuticals has risen higher in 8 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Supernus Pharmaceuticals Stock Undervalued?
The current Supernus Pharmaceuticals [SUPN] share price is $36.16. The Score for SUPN is 28, which is 44% below its historic median score of 50, and infers higher risk than normal. - SUPN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Supernus Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Supernus Pharmaceuticals has on average historically risen by 20.3% based on the past 12 years of stock performance.
Supernus Pharmaceuticals Stock Rating
Sell
28
Supernus Pharmaceuticals (SUPN)
is a Sell
Is Supernus Pharmaceuticals overpriced?
- Supernus Pharmaceuticals has risen higher in 8 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Supernus Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
supernus.com
52-Week Data
52-Week High:
39.37
52-Week Low:
25.53
Prediction Charts
Market Cap:
2B
Price in USD:
36.16
Volume:
322.04K
Beta:
1.09
Technical Analysis
SMA50:
35.09
SMA100:
33.66
SMA200:
31.65
52-Wk Change:
36.09%
Stock Predictions
-
Is Supernus Pharmaceuticals stock public?
Yes, Supernus Pharmaceuticals is a publicly traded company. -
What is the Supernus Pharmaceuticals stock quote today?
The Supernus Pharmaceuticals stock price is 36.16 USD today. -
How to buy Supernus Pharmaceuticals stock online?
You can buy Supernus Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-22 | 36.06 | 36.22 | 36.66 | 35.85 |
| Nov-25 | 36.55 | 36.10 | 37.21 | 36.10 |
| Nov-26 | 36.11 | 36.14 | 36.59 | 35.85 |
| Nov-27 | 36.43 | 36.99 | 37.23 | 36.03 |
| Nov-29 | 36.91 | 36.57 | 37.05 | 36.15 |
| Dec-2 | 36.45 | 37.31 | 37.41 | 36.16 |
| Dec-3 | 37.24 | 37.03 | 37.24 | 36.21 |
| Dec-4 | 36.84 | 37.15 | 37.52 | 36.67 |
| Dec-5 | 36.83 | 36.99 | 37.44 | 36.20 |
| Dec-6 | 37.12 | 37.17 | 37.48 | 36.74 |
| Dec-9 | 37.19 | 36.68 | 37.62 | 36.61 |
| Dec-10 | 36.79 | 36.74 | 37.27 | 36.48 |
| Dec-11 | 37.01 | 36.85 | 37.28 | 36.59 |
| Dec-12 | 36.87 | 36.16 | 36.97 | 36.11 |
Supernus Pharmaceuticals Earnings
Supernus Pharmaceuticals Earnings Report: Per Share Supernus Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Supernus Pharmaceuticals Forecast Revenue Growth
Supernus Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Supernus Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.87 per share, and a decrease next year of $0.96 per share.
* Supernus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.